Maplelane Capital’s Imperva, Inc. IMPV Stock Holding History

Maplelane Capital’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,100	Closed	-$5.26M	–	211
2017 Q2	$5.26M	Sell	1,100 -238,900	-100%	-$11.1M	0.1%	103
2017 Q1	$9.85M	Buy	+240,000	New	+$10M	0.26%	71

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Maplelane Capital's IMPV Position: Q3 2017 in Review

Maplelane Capital sold out of Imperva, Inc. (IMPV) in Q3 2017, closing a stake of 55,001 shares — an estimated $2.63M sold.

Maplelane Capital first reported a position in IMPV in Q1 2017 and held it in 2 quarters. The position peaked at $2.63M in Q2 2017. 171 funds tracked by Wall St. Rank hold IMPV as of Q3 2017.

Maplelane Capital reported no remaining Imperva, Inc. position as of Q3 2017 after selling out during the quarter.
Maplelane Capital sold 55,001 Imperva, Inc. shares in Q3 2017, an estimated $2.63M.
Maplelane Capital first reported a position in Imperva, Inc. in Q1 2017 and held it in 2 quarters.
Maplelane Capital's Imperva, Inc. position peaked at $2.63M in Q2 2017.
171 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2017.

Based on Maplelane Capital's 13F filing for Q3 2017, filed 14 Nov 2017.